[go: up one dir, main page]

AU2001248750A1 - Novel physiologically active peptides and use thereof - Google Patents

Novel physiologically active peptides and use thereof

Info

Publication number
AU2001248750A1
AU2001248750A1 AU2001248750A AU4875001A AU2001248750A1 AU 2001248750 A1 AU2001248750 A1 AU 2001248750A1 AU 2001248750 A AU2001248750 A AU 2001248750A AU 4875001 A AU4875001 A AU 4875001A AU 2001248750 A1 AU2001248750 A1 AU 2001248750A1
Authority
AU
Australia
Prior art keywords
physiologically active
active peptides
novel physiologically
novel
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248750A
Inventor
Satoshi Kumano
Tetsuya Ohtaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001248750A1 publication Critical patent/AU2001248750A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
AU2001248750A 2000-04-11 2001-04-11 Novel physiologically active peptides and use thereof Abandoned AU2001248750A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-109382 2000-04-11
JP2000109382 2000-04-11
PCT/JP2001/003112 WO2001077166A1 (en) 2000-04-11 2001-04-11 Novel physiologically active peptides and use thereof

Publications (1)

Publication Number Publication Date
AU2001248750A1 true AU2001248750A1 (en) 2001-10-23

Family

ID=18622085

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248750A Abandoned AU2001248750A1 (en) 2000-04-11 2001-04-11 Novel physiologically active peptides and use thereof

Country Status (4)

Country Link
US (1) US20040091960A1 (en)
EP (1) EP1275659A4 (en)
AU (1) AU2001248750A1 (en)
WO (1) WO2001077166A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077531A1 (en) * 2001-01-19 2004-04-22 Hirokazu Matsumoto Use of galanin-like peptide
EP1437367A4 (en) * 2001-09-26 2005-01-26 Takeda Pharmaceutical ANTIBODIES AND ITS USE
AU2003211562A1 (en) * 2002-02-22 2003-09-09 Takeda Chemical Industries, Ltd. Novel dna and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2323503C (en) * 1998-03-25 2010-09-28 Takeda Chemical Industries, Ltd. Novel physiological active peptide and its use
JP2000270871A (en) * 1999-03-24 2000-10-03 Takeda Chem Ind Ltd Production of new physiologically active peptide

Also Published As

Publication number Publication date
US20040091960A1 (en) 2004-05-13
EP1275659A4 (en) 2004-05-19
EP1275659A1 (en) 2003-01-15
WO2001077166A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
AU2575000A (en) Collagen-binding physiologically active polypeptide
AU2001268326A1 (en) Peptides with physiological activity
EP1462455A4 (en) Novel peptides and medicinal uses thereof
AU2001292574A1 (en) Human phermone polypeptide
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001277696A1 (en) Novel physiologically active peptide and use thereof
AU2002230129A1 (en) Novel physiologically active peptide and use thereof
AU2001266347A1 (en) Enteric preparations containing physiologically active peptides
GB0026134D0 (en) Peptides and their use
AU6179600A (en) Peptides and pharmaceutical compositions comprising same
AU4876701A (en) Peptide derivatives and medicinal compositions
AU2001248750A1 (en) Novel physiologically active peptides and use thereof
AU2001296389A1 (en) Stable peptide formulations
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001277519A1 (en) Bio-probes and use thereof
AU2001263287A1 (en) Human protein kinase "13305" and uses therefor
AU2001252621A1 (en) Novel proetin and use thereof
AU2001250585A1 (en) Insecticidal peptides and methods for using same
AU1179600A (en) Physiologically active peptides
AU2002228415A1 (en) Novel physiologically active peptide and use thereof
AU2001231141A1 (en) Novel human septin and uses thereof
AU2001263237A1 (en) 57256 and 58289, human transporters and uses thereof
AU5055900A (en) Bacteriocin, preparation and use thereof
AU4328500A (en) Retro-inverso prosaposin-derived peptides and use thereof